117 related articles for article (PubMed ID: 9814774)
1. Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex dose in rats.
Rogers JM; Jung CW; Lewis J; Groman EV
Magn Reson Imaging; 1998 Oct; 16(8):917-23. PubMed ID: 9814774
[TBL] [Abstract][Full Text] [Related]
2. Detection sensitivity of lymph nodes of various sizes using USPIO nanoparticles in magnetic resonance imaging.
Oghabian MA; Gharehaghaji N; Amirmohseni S; Khoei S; Guiti M
Nanomedicine; 2010 Jun; 6(3):496-9. PubMed ID: 20044032
[TBL] [Abstract][Full Text] [Related]
3. Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat.
Muldoon LL; Varallyay P; Kraemer DF; Kiwic G; Pinkston K; Walker-Rosenfeld SL; Neuwelt EA
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):70-9. PubMed ID: 14720178
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
5. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
[TBL] [Abstract][Full Text] [Related]
7. [Sentinel lymph node after intramammary injection of superparamagnetic iron oxide].
Ishiyama K; Sashi R; Katayose Y; Tomura N; Watarai J; Narita K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Nov; 62(13):744-6. PubMed ID: 12508494
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.
Bengele HH; Palmacci S; Rogers J; Jung CW; Crenshaw J; Josephson L
Magn Reson Imaging; 1994; 12(3):433-42. PubMed ID: 8007773
[TBL] [Abstract][Full Text] [Related]
9. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection.
Réty F; Clément O; Siauve N; Cuénod CA; Carnot F; Sich M; Buisine A; Frija G
J Magn Reson Imaging; 2000 Nov; 12(5):734-9. PubMed ID: 11050643
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
[TBL] [Abstract][Full Text] [Related]
11. [Identification of sentinel lymph nodes and mapping procedure of sentinel lymph nodes for breast cancer].
Nohara T; Harada T; Tanigawa N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():193-7. PubMed ID: 17682156
[No Abstract] [Full Text] [Related]
12. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
[TBL] [Abstract][Full Text] [Related]
13. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations.
Koh DM; Brown G; Temple L; Raja A; Toomey P; Bett N; Norman AR; Husband JE
Radiology; 2004 Apr; 231(1):91-9. PubMed ID: 14976266
[TBL] [Abstract][Full Text] [Related]
14. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
16. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
17. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex).
Harisinghani MG; Saini S; Hahn PF; Weissleder R; Mueller PR
Acad Radiol; 1998 Apr; 5 Suppl 1():S167-9, discussion S183-4. PubMed ID: 9561072
[No Abstract] [Full Text] [Related]
19. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO.
Stets C; Brandt S; Wallis F; Buchmann J; Gilbert FJ; Heywang-Köbrunner SH
J Magn Reson Imaging; 2002 Jul; 16(1):60-8. PubMed ID: 12112504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]